Publications by authors named "Toru Shimazui"

Claim this Profile
I
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer.
Tokiyoshi Tanegashima, Masaki Shiota, Naoki Terada, Toshihiro Saito, Akira Yokomizo, Toru Shimazui

Int J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.
Keita Minami, Takahiro Osawa, Takahiro Kojima, Tomohiko Hara, Masatoshi Eto, Toru Shimazui

Urol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abdominal nonfunctional paraganglioma in which succinate dehydrogenase subunit B (SDHB) immunostaining was performed: a case report.
Takazo Tanaka, Akira Joraku, Sayuri Ishibashi, Keisuke Endo, Masahiro Emura, Toru Shimazui

J Med Case Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELOVL5-mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma.
Satoshi Nitta, Shuya Kandori, Ken Tanaka, Shotaro Sakka, Masanobu Siga, Toru Shimazui

Cancer Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR.
Takashi Kobayashi, Katsuhiro Ito, Takahiro Kojima, Satoru Maruyama, Shoichiro Mukai, Toru Shimazui

Cancer Immunol Immunother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.
Ken Tanaka, Shuya Kandori, Shotaro Sakka, Satoshi Nitta, Kozaburo Tanuma, Toru Shimazui

Oncol Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching.
Naotaka Nishiyama, Takashi Kobayashi, Shintaro Narita, Yu Hidaka, Katsuhiro Ito, Toru Shimazui

J Geriatr Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancer.
Masaki Shiota, Naoki Terada, Hiroshi Kitamura, Takahiro Kojima, Toshihiro Saito, Toru Shimazui

Cancer Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma.
Yasutomo Nakai, Ario Takeuchi, Takahiro Osawa, Takahiro Kojima, Tomohiko Hara, Toru Shimazui

J Geriatr Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Renal Mucinous Tubular and Spindle Cell Carcinoma : A Case Report].
Kazuki Hamada, Akira Joraku, Daishi Ichioka, Masahiro Emura, Toru Shimazui

Hinyokika Kiyo· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients.
Masaki Shiota, Naoki Terada, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Toru Shimazui

Cancer Sci· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer.
Naoki Terada, Takashi Mizowaki, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Toru Shimazui

BJUI Compass· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma.
Takahiro Osawa, Takahiro Kojima, Tomohiko Hara, Mikio Sugimoto, Masatoshi Eto, Toru Shimazui

Cancer Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.
Takuya Koie, Chikara Ohyama, Kazuhide Makiyama, Toru Shimazui, Tomoaki Miyagawa

Int J Urol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic transduction of p16 antitumor peptide inhibits lung metastasis of the MBT-2 bladder tumor cell line in mice.
Toru Shimazui, Kazuhiro Yoshikawa, Ryutaro Ishitsuka, Takahiro Kojima, Shuya Kandori

Oncol Lett· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.
Shuya Kandori, Takahiro Kojima, Taeko Matsuoka, Takayuki Yoshino, Aiko Sugiyama, Toru Shimazui

Cancer Sci· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous reference RNAs for microRNA quantitation in formalin-fixed, paraffin-embedded lymph node tissue.
Katsushige Inada, Yasushi Okoshi, Yukiko Cho-Isoda, Shingo Ishiguro, Hisashi Suzuki, Toru Shimazui

Sci Rep· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Toru Shimazui

Jpn J Clin Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[II. What Is the Future of Robot-Assisted Laparoscopic Radical Prostatectomy in Japan ?].
Toru Shimazui, Atsushi Yamauchi, Masahiro Emura, Mikinobu Ohtani

Gan To Kagaku Ryoho· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of classical secondary hormonal therapies prior to docetaxel therapy in Japanese patients with castration-resistant prostate cancer: Multicenter retrospective study.
Shuya Kandori, Takayuki Yoshino, Masakazu Tsutsumi, Atsushi Yamauchi, Mikinobu Ohtani, Toru Shimazui

Prostate Int· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Combined androgen blockade for prostate cancer].
Toru Shimazui

Nihon Rinsho· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery.
Masato Sakon, Yoshihiko Maehara, Takao Kobayashi, Hiroshi Kobayashi, Toru Shimazui

Value Health Reg Issues· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncological outcomes of metastatic testicular cancers under centralized management through regional medical network.
Hiromu Inai, Koji Kawai, Takahiro Kojima, Akira Joraku, Toru Shimazui

Jpn J Clin Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy.
Atsushi Ochiai, Koji Okihara, Kazumi Kamoi, Takehiro Oikawa, Toru Shimazui

BJU Int· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic transduction of p16INK4A antitumor peptide inhibits the growth of MBT-2 mouse bladder tumor cell line grafts.
Toru Shimazui, Kazuhiro Yoshikawa, Jun Miyazaki, Takahiro Kojima, Hiromu Inai

Int J Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis